The prognostic implication of ascites in advanced-stage ovarian cancer

Gynecologic Oncology

Volumn 61, Issue 1, 1996, Pages 109-112

  Puls, Larry E ^a   Duniho, Timothy ^b   Hunter IV, James E ^b   Kryscio, Richard ^b   Blackhurst, Dawn ^c   Gallion, Holly ^b  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^c GREENVILLE HOSPITAL SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVANCED CANCER; ARTICLE; ASCITES; CANCER MORTALITY; CANCER STAGING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; UNITED STATES;

EID: 0029923157     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1996.0106     Document Type: Article

References (19)

1. Cancer Stat. 45(1), 12-30 (1995).
2. Marsoni, S., Torri, V., and Valsecchi, M. G., Belloni, C., Bianchi, U., Bolis, G., Bonazzi, C., Colombo, N., Epis, A., Favalli, G., Gambino, A., Landoni, F., Maggi, R., Pecorelli, S., Presti, S., Vassena, L., Zanaboni, F., and Mangioni, C. Prognostic factors in advanced epithelial ovarian cancer, Br. J. Cancer 62, 444-450 (1990).
3. Day, T., Gallager, H. S., and Rutledge, F. N. Epithelial carcinoma of the ovary: Prognostic importance of histologic grade, Natl. Ca Inst. Monogr 42, 15-16.
4. Makar, A., Baekelandt, M., Trope, G. C., and Kristensen, G. B. The prognostic significance of residual disease, FIGO substage, tumor histology and grade in patients with FIGO stage III ovarian cancer, Gynecol. Oncol. 56, 175-180 (1995).
5. Redman, J. R., Petroni, G. R., Saigo, P. E., Geller, N. L., and Hakes, T. B. Prognostic factors in advanced ovarian carcinoma, J. Clin. Oncol. 2, 515-523 (1986).
6. Flam, F., Einhorn, N., and Sjovall, K. Symptomatology of ovarian cancer, Eur. J. Obstet. Gynecol. Reprod. Biol. 27, 53 (1988).
7. Granberg, S., Noren, H., and Friberg, L. Ovarian cancer stages I and II: Predictions and 5-year survival in two decades, Gynecol. Oncol. 35, 204-208 (1989).
8. Dembo, A. J., Davy, M., Stenwig, A. E., Berle, E. J., Bush, R. S., and Kjorstad, K. Prognostic factors in patients with stage I epithelial ovarian cancer, Obstet. Gynecol. 75, 263-273 (1990).
9. Fred, J., and Vooijs, C. P. Survival of patients with malignancy-associated effusions, Acta Cytol. 33(6), 911-916 (1989).
10. Berek, J. S., Hacker, N. F., LaGasse, L. D., Poth, T., Resnick, B., and Nieberg, R. K. Second-look laparatomy in stage III epithelial ovarian cancer: Clinical variables associated with disease status, Obstet. Gynecol. 64(2), (1984).
11. Decker, D. G., Malkasian, G. D., and Taylor, W. F. Prognostic importance of histologic grading in ovarian carcinoma, Natl. Cancer Inst. Monogr 42, 9-11 (1975).
12. International Federation of Gynecology and Obstetrics (FIGO). Changes in gynecologic cancer staging by the International Federation of Gynecology and Obstetrics, Am. J. Obstet. Gynecol. 162, 610 (1990).
13. Russell, P., and Bannatyne, P. Surgical pathology of the ovaries, Churchill Livingstone, New York, pp. 190-216 (1989).
14. Russell, P., and Bannatyne, P. Surgical pathology of the ovaries, Churchill Livingstone, New York, pp. 217-235 (1989).
15. Coppleson, M., Monaghan, J. M., Morrow, C. P., and Tattersall, M. H. N. Gynecologic Oncology, 2nd ed., p. 897 (1992).
16. Holm-Nielsen, P. Pathogenesis of ascites in peritoneal carcinomatosis, Acta Pathol. Microbiol. Scand. 33, 10-21 (1953).
17. Hirabayashi, K., and Graham, J. The genesis of ascites in ovarian cancer, Am. J. Obstet. Gynecol. 106, 492-497 (1970).
18. Feldman, G. B., Knapp, R. C., Order, S. E., and Hellman, S. The role of lymphatic obstruction in the formation of ascites in a murine ovarian carcinoma, Cancer Res. 32, 1663-1666 (1972).
19. Schwartz, P. E., Chambers, J. T., and Makuch, R. Neoadjuvant chemotherapy for advanced ovarian cancer, Gynecol. Oncol. 53, 33-37 (1994).